I agree that this site is using cookies. You can find further informations here.
X
Garajová, I.
44  results:
Search for persons X
?
1

Sorafenib as a second-line treatment after failure of atezo..:

Tovoli, F. ; Boe, M. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S79 , 2024
Link: https://doi.org/10.1016/..
 
?
2

189P The synergic effect of metformin and atezolizumab/beva..:

Dalbeni, A. ; Auriemma, A. ; Stefanini, B....
Annals of Oncology.  35 (2024)  - p. S85 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Management of portal hypertension in patients receiving ate..:

Tovoli, F. ; Franceschini, E. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S87 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S92-S93 , 2024
Link: https://doi.org/10.1016/..
 
?
5

The impact of etiology on patterns of progression of advanc..:

Stefanini, B. ; Piscaglia, F. ; Dalbeni, A....
Digestive and Liver Disease.  56 (2024)  - p. S17 , 2024
Link: https://doi.org/10.1016/..
 
?
6

The synergic effect of metformin with atezolizumab/ bevaciz..:

Dalbeni, A. ; Vicardi, M. ; Natola, L.A....
Digestive and Liver Disease.  56 (2024)  - p. S89-S90 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and safety of atezolizumab/bevacizumab for hepatoc..:

Tovoli, F. ; Vivaldi, C. ; Federico, P....
Digestive and Liver Disease.  56 (2024)  - p. S85-S86 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Advances in the management of hepatobiliary and pancreatic ..:

Fulgenzi, C. ; Garajová, I. ; Moehler, M....
ESMO Gastrointestinal Oncology.  3 (2024)  - p. 100039 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Clinical impact of relative dose intensity of cabozantinib ..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease.  55 (2023)  - p. S224-S225 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Updates on the biomarker status of the human equilibrative ..:

Mantini, G. ; Papini, F. ; Capula, M....
Pancreatology.  21 (2021)  - p. S71 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Chemotherapy toxicity and activity in patients with pancrea..:

Orsi, G. ; Di Marco, M. ; Cavaliere, A....
ESMO Open.  6 (2021)  5 - p. 100238 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Real-life clinical data of cabozantinib for unresectable he..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease.  53 (2021)  - p. S10 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Pattern of progression of intrahepatic cholangiocarcinoma i..:

Tovoli, F. ; Garajovà, I. ; Iavarone, M....
Digestive and Liver Disease.  53 (2021)  - p. S19 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Membrane human equilibrative nucleoside transporter 1 is as..:

Tavolari, S. ; Deserti, M. ; Vasuri, F....
European Journal of Cancer.  106 (2019)  - p. 160-170 , 2019
Link: https://doi.org/10.1016/..
 
?
15

219 MiR-21 expression correlates with prognosis in extrahep..:

Garajová, I. ; Brandi, G. ; Biasco, G....
European Journal of Cancer.  51 (2015)  - p. S33 , 2015
Link: https://doi.org/10.1016/..
 
1-15